[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Bio-pharma Market Status, Trends and COVID-19 Impact Report 2022

September 2022 | 115 pages | ID: G3C3E5817FD8EN
BisReport Information Consulting CO., Ltd

US$ 2,350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In the past few years, the Bio-pharma market experienced a huge change under the influence of COVID-19, the global market size of Bio-pharma reached xx million $ in 2021 from xx in 2016 with a CAGR of xx from 2016-2021 is. As of now, the global COVID-19 Coronavirus Cases have exceeded 500 million, and the global epidemic has been basically under control, therefore, the World Bank has estimated the global economic growth in 2021 and 2022. The World Bank predicts that the global economic output is expected to expand 4 percent in 2021 while 3.8 percent in 2022. According to our research on Bio-pharma market and global economic environment, we forecast that the global market size of Bio-pharma will reach xx million $ in 2027 with a CAGR of % from 2022-2027.

Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to recover and partially adapted to pandemic restrictions. The research and development of vaccines has made breakthrough progress, and many governments have also issued various policies to stimulate economic recovery, particularly in the United States, is likely to provide a strong boost to economic activity but prospects for sustainable growth vary widely between countries and sectors. Although the global economy is recovering from the great depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged period. The pandemic has exacerbated the risks associated with the decade-long wave of global debt accumulation. It is also likely to steepen the long-expected slowdown in potential growth over the next decade.

The world has entered the COVID-19 epidemic recovery period. In this complex economic environment, we published the Global Bio-pharma Market Status, Trends and COVID-19 Impact Report 2022, which provides a comprehensive analysis of the global Bio-pharma market , This Report covers the manufacturer data, including: sales volume, price, revenue, gross margin, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows the regional development status, including market size, volume and value, as well as price data. Besides, the report also covers segment data, including: type wise, industry wise, channel wise etc. all the data period is from 2016-2021, this report also provide forecast data from 2022-2027.

Section 1: 100 USD——Market Overview

Section (2 3): 1200 USD——Manufacturer Detail
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
AbbVie
Merck & Co., Inc
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories

Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)

Section (5 6 7): 700 USD——
Product Type Segmentation
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin/Erythropoietin/Vaccines/Growth Hormones/Purified Proteins

Application Segmentation
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases

Channel (Direct Sales, Distribution Channel) Segmentation

Section 8: 500 USD——Market Forecast (2022-2027)

Section 9: 600 USD——Downstream Customers

Section 10: 200 USD——Raw Material and Manufacturing Cost

Section 11: 500 USD——Conclusion

Section 12: Research Method and Data Source
SECTION 1 BIO-PHARMA MARKET OVERVIEW

1.1 Bio-pharma Market Scope
1.2 COVID-19 Impact on Bio-pharma Market
1.3 Global Bio-pharma Market Status and Forecast Overview
  1.3.1 Global Bio-pharma Market Status 2016-2021
  1.3.2 Global Bio-pharma Market Forecast 2022-2027

SECTION 2 GLOBAL BIO-PHARMA MARKET MANUFACTURER SHARE

2.1 Global Manufacturer Bio-pharma Sales Volume
2.2 Global Manufacturer Bio-pharma Business Revenue

SECTION 3 MANUFACTURER BIO-PHARMA BUSINESS INTRODUCTION

3.1 Pfizer Bio-pharma Business Introduction
  3.1.1 Pfizer Bio-pharma Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.1.2 Pfizer Bio-pharma Business Distribution by Region
  3.1.3 Pfizer Interview Record
  3.1.4 Pfizer Bio-pharma Business Profile
  3.1.5 Pfizer Bio-pharma Product Specification
3.2 F. Hoffmann-La Roche AG Bio-pharma Business Introduction
  3.2.1 F. Hoffmann-La Roche AG Bio-pharma Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.2.2 F. Hoffmann-La Roche AG Bio-pharma Business Distribution by Region
  3.2.3 Interview Record
  3.2.4 F. Hoffmann-La Roche AG Bio-pharma Business Overview
  3.2.5 F. Hoffmann-La Roche AG Bio-pharma Product Specification
3.3 Manufacturer three Bio-pharma Business Introduction
  3.3.1 Manufacturer three Bio-pharma Sales Volume, Price, Revenue and Gross margin 2016-2021
  3.3.2 Manufacturer three Bio-pharma Business Distribution by Region
  3.3.3 Interview Record
  3.3.4 Manufacturer three Bio-pharma Business Overview
  3.3.5 Manufacturer three Bio-pharma Product Specification

SECTION 4 GLOBAL BIO-PHARMA MARKET SEGMENTATION (BY REGION)

4.1 North America Country
  4.1.1 United States Bio-pharma Market Size and Price Analysis 2016-2021
  4.1.2 Canada Bio-pharma Market Size and Price Analysis 2016-2021
  4.1.3 Mexico Bio-pharma Market Size and Price Analysis 2016-2021
4.2 South America Country
  4.2.1 Brazil Bio-pharma Market Size and Price Analysis 2016-2021
  4.2.2 Argentina Bio-pharma Market Size and Price Analysis 2016-2021
4.3 Asia Pacific
  4.3.1 China Bio-pharma Market Size and Price Analysis 2016-2021
  4.3.2 Japan Bio-pharma Market Size and Price Analysis 2016-2021
  4.3.3 India Bio-pharma Market Size and Price Analysis 2016-2021
  4.3.4 Korea Bio-pharma Market Size and Price Analysis 2016-2021
  4.3.5 Southeast Asia Bio-pharma Market Size and Price Analysis 2016-2021
4.4 Europe Country
  4.4.1 Germany Bio-pharma Market Size and Price Analysis 2016-2021
  4.4.2 UK Bio-pharma Market Size and Price Analysis 2016-2021
  4.4.3 France Bio-pharma Market Size and Price Analysis 2016-2021
  4.4.4 Spain Bio-pharma Market Size and Price Analysis 2016-2021
  4.4.5 Italy Bio-pharma Market Size and Price Analysis 2016-2021
4.5 Middle East and Africa
  4.5.1 Africa Bio-pharma Market Size and Price Analysis 2016-2021
  4.5.2 Middle East Bio-pharma Market Size and Price Analysis 2016-2021
4.6 Global Bio-pharma Market Segmentation (By Region) Analysis 2016-2021
4.7 Global Bio-pharma Market Segmentation (By Region) Analysis

SECTION 5 GLOBAL BIO-PHARMA MARKET SEGMENTATION (BY PRODUCT TYPE)

5.1 Product Introduction by Type
  5.1.1 Monoclonal Antibodies Product Introduction
  5.1.2 Recombinant Proteins Product Introduction
  5.1.3 Granulocyte-Colony Stimulating Factor (G-CSF) Product Introduction
  5.1.4 Interferons Product Introduction
  5.1.5 Recombinant Human Insulin/Erythropoietin/Vaccines/Growth Hormones/Purified Proteins Product Introduction
5.2 Global Bio-pharma Sales Volume by Recombinant Proteins016-2021
5.3 Global Bio-pharma Market Size by Recombinant Proteins016-2021
5.4 Different Bio-pharma Product Type Price 2016-2021
5.5 Global Bio-pharma Market Segmentation (By Type) Analysis

SECTION 6 GLOBAL BIO-PHARMA MARKET SEGMENTATION (BY APPLICATION)

6.1 Global Bio-pharma Sales Volume by Application 2016-2021
6.2 Global Bio-pharma Market Size by Application 2016-2021
6.2 Bio-pharma Price in Different Application Field 2016-2021
6.3 Global Bio-pharma Market Segmentation (By Application) Analysis

SECTION 7 GLOBAL BIO-PHARMA MARKET SEGMENTATION (BY CHANNEL)

7.1 Global Bio-pharma Market Segmentation (By Channel) Sales Volume and Share 2016-2021
7.2 Global Bio-pharma Market Segmentation (By Channel) Analysis

SECTION 8 BIO-PHARMA MARKET FORECAST 2022-2027

8.1 Bio-pharma Segmentation Market Forecast 2022-2027 (By Region)
8.2 Bio-pharma Segmentation Market Forecast 2022-2027 (By Type)
8.3 Bio-pharma Segmentation Market Forecast 2022-2027 (By Application)
8.4 Bio-pharma Segmentation Market Forecast 2022-2027 (By Channel)
8.5 Global Bio-pharma Price Forecast

SECTION 9 BIO-PHARMA APPLICATION AND CLIENT ANALYSIS

9.1 Metabolic Disorders Customers
9.2 Oncology Customers
9.3 Neurological Disorders Customers
9.4 Cardiovascular Diseases Customers
9.5 Inflammatory and Infectious Diseases Customers

SECTION 10 BIO-PHARMA MANUFACTURING COST OF ANALYSIS

11.0 Raw Material Cost Analysis
11.0 Labor Cost Analysis
11.0 Cost Overview

SECTION 11 CONCLUSION

SECTION 12 METHODOLOGY AND DATA SOURCE

CHART AND FIGURE

Figure Bio-pharma Product Picture
Chart Global Bio-pharma Market Size (with or without the impact of COVID-19)
Chart Global Bio-pharma Sales Volume (Units) and Growth Rate 2016-2021
Chart Global Bio-pharma Market Size (Million $) and Growth Rate 2016-2021
Chart Global Bio-pharma Sales Volume (Units) and Growth Rate 2022-2027
Chart Global Bio-pharma Market Size (Million $) and Growth Rate 2022-2027
Chart 2016-2021 Global Manufacturer Bio-pharma Sales Volume (Units)
Chart 2016-2021 Global Manufacturer Bio-pharma Sales Volume Share
Chart 2016-2021 Global Manufacturer Bio-pharma Business Revenue (Million USD)
Chart 2016-2021 Global Manufacturer Bio-pharma Business Revenue Share
Chart Pfizer Bio-pharma Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart Pfizer Bio-pharma Business Distribution
Chart Pfizer Interview Record (Partly)
Chart Pfizer Bio-pharma Business Profile
Table Pfizer Bio-pharma Product Specification
Chart F. Hoffmann-La Roche AG Bio-pharma Sales Volume, Price, Revenue and Gross margin 2016-2021
Chart F. Hoffmann-La Roche AG Bio-pharma Business Distribution
Chart F. Hoffmann-La Roche AG Interview Record (Partly)
Chart F. Hoffmann-La Roche AG Bio-pharma Business Overview
Table F. Hoffmann-La Roche AG Bio-pharma Product Specification
Chart United States Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart United States Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart Canada Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Canada Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart Mexico Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Mexico Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart Brazil Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Brazil Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart Argentina Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Argentina Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart China Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart China Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart Japan Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Japan Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart India Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart India Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart Korea Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Korea Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart Southeast Asia Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Southeast Asia Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart Germany Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Germany Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart UK Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart UK Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart France Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart France Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart Spain Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Spain Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart Italy Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Italy Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart Africa Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Africa Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart Middle East Bio-pharma Sales Volume (Units) and Market Size (Million $) 2016-2021
Chart Middle East Bio-pharma Sales Price (USD/Unit) 2016-2021
Chart Global Bio-pharma Market Segmentation Sales Volume (Units) by Region 2016-2021
Chart Global Bio-pharma Market Segmentation Sales Volume (Units) Share by Region 2016-2021
Chart Global Bio-pharma Market Segmentation Market size (Million $) by Region 2016-2021
Chart Global Bio-pharma Market Segmentation Market size (Million $) Share by Region 2016-2021
Chart Monoclonal Antibodies Product Figure
Chart Monoclonal Antibodies Product Description
Chart Recombinant Proteins Product Figure
Chart Recombinant Proteins Product Description
Chart Granulocyte-Colony Stimulating Factor (G-CSF) Product Figure
Chart Granulocyte-Colony Stimulating Factor (G-CSF) Product Description
Chart Bio-pharma Sales Volume (Units) by Recombinant Proteins016-2021
Chart Bio-pharma Sales Volume (Units) Share by Type
Chart Bio-pharma Market Size (Million $) by Recombinant Proteins016-2021
Chart Bio-pharma Market Size (Million $) Share by Recombinant Proteins016-2021
Chart Different Bio-pharma Product Type Price ($/Unit) 2016-2021
Chart Bio-pharma Sales Volume (Units) by Application 2016-2021
Chart Bio-pharma Sales Volume (Units) Share by Application
Chart Bio-pharma Market Size (Million $) by Application 2016-2021
Chart Bio-pharma Market Size (Million $) Share by Application 2016-2021
Chart Bio-pharma Price in Different Application Field 2016-2021
Chart Global Bio-pharma Market Segmentation (By Channel) Sales Volume (Units) 2016-2021
Chart Global Bio-pharma Market Segmentation (By Channel) Share 2016-2021
Chart Bio-pharma Segmentation Market Sales Volume (Units) Forecast (by Region) 2022-2027
Chart Bio-pharma Segmentation Market Sales Volume Forecast (By Region) Share 2022-2027
Chart Bio-pharma Segmentation Market Size (Million USD) Forecast (By Region) 2022-2027
Chart Bio-pharma Segmentation Market Size Forecast (By Region) Share 2022-2027
Chart Bio-pharma Market Segmentation (By Type) Volume (Units) 2022-2027
Chart Bio-pharma Market Segmentation (By Type) Volume (Units) Share 2022-2027
Chart Bio-pharma Market Segmentation (By Type) Market Size (Million $) 2022-2027
Chart Bio-pharma Market Segmentation (By Type) Market Size (Million $) 2022-2027
Chart Bio-pharma Market Segmentation (By Application) Market Size (Volume) 2022-2027
Chart Bio-pharma Market Segmentation (By Application) Market Size (Volume) Share 2022-2027
Chart Bio-pharma Market Segmentation (By Application) Market Size (Value) 2022-2027
Chart Bio-pharma Market Segmentation (By Application) Market Size (Value) Share 2022-2027
Chart Global Bio-pharma Market Segmentation (By Channel) Sales Volume (Units) 2022-2027
Chart Global Bio-pharma Market Segmentation (By Channel) Share 2022-2027
Chart Global Bio-pharma Price Forecast 2022-2027
Chart Metabolic Disorders Customers
Chart Oncology Customers
Chart Neurological Disorders Customers
Chart Cardiovascular Diseases Customers


More Publications